Star Therapeutics Raises $200 Million To Advance Preclinical Pipeline Into The Clinic
By Amit Chowdhry ● Oct 23, 2026
Star Therapeutics has raised $200 million in private financing to advance its next generation of therapeutic programs, move current preclinical assets into clinical development, and expand its pipeline with additional programs. The financing was co-led by OrbiMed and Janus Henderson Investors. Other participants included Agent Capital, Catalio Capital Management, Cormorant Asset Management, New Leaf Venture Partners, NYBC Ventures, RA Capital Management, Redmile, Sofinnova Investments, Soleus Capital, and a sovereign wealth fund.